Authors/Disclosures
|
Adriano Chio, MD, FAAN
(Dept. of Neuroscience, University of Turin)
|
Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. |
|
Fariha Jamal, MD
|
Dr. Jamal has nothing to disclose. |
|
|
No disclosure on file |
|
Adam Kirton, MD
(Alberta Children'S Hospital)
|
Dr. Kirton has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple. The institution of Dr. Kirton has received research support from Multiple. |
|
Maura Pugliatti, MD
|
No disclosure on file |
|
Anna Ticca
|
No disclosure on file |
|
Andrea Calvo, MD, PhD, FAAN
(Dept. of Neuroscience, University of Turin)
|
Dr. Calvo has nothing to disclose. |
|
Cristina Moglia
(University of Torino)
|
Cristina Moglia has nothing to disclose. |
|
Maura Brunetti
|
No disclosure on file |
|
|
No disclosure on file |
|
Maria G. Marrosu
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Paola Cossu
(Clinica Neurologica)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Bryan Traynor, MD
(National Institute on Aging)
|
The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |